Mitral valve abnormalities and catecholamine activity in anxious patients.
We studied 38 anxiety disorder patients, 19 of whom had evidence of mitral valve abnormalities by two-dimensional echocardiography. The presence or absence of mitral valve abnormalities was not related to 3-methoxy-4-hydroxyphenylglycol/creatinine excretion, platelet and plasma monoamine oxidase-type activity, or autonomic arousal as measured by blood pressure and resting heart rate. These findings fail to support the hypothesis that mitral valve abnormalities identify a specific subpopulation of anxious patients with differences in catecholamine function.
D000328:Adult; D001008:Anxiety Disorders / Q000503:physiopathology*; D001143:Arousal / Q000502:physiology; D002395:Catecholamines / Q000097:blood*; D004452:Echocardiography; D005260:Female; D006801:Humans; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000652:urine; D008943:Mitral Valve / Q000503:physiopathology*; D008945:Mitral Valve Prolapse / Q000503:physiopathology*; D008995:Monoamine Oxidase / Q000097:blood; D010200:Panic / Q000502:physiology
D002395:Catecholamines; D008734:Methoxyhydroxyphenylglycol; D008995:Monoamine Oxidase